122 related articles for article (PubMed ID: 26219108)
21. [Ischemic anastomotic bowel perforation during treatment with bevacizumab 10 months after surgery].
Abbrederis K; Kremer M; Schuhmacher C
Chirurg; 2008 Apr; 79(4):351-5. PubMed ID: 17453167
[TBL] [Abstract][Full Text] [Related]
22. Dual deficiency of DPD and UGT1A1 in a case of colon cancer.
Rawlley B; Diab O; Al-Rajabi R; Carroll E; Melancon T; Kasi A
Pharmacogenomics; 2020 Dec; 21(18):1265-1269. PubMed ID: 33203301
[No Abstract] [Full Text] [Related]
23. [A case of interstitial pneumonitis induced by FOLFIRI+bevacizumab combination therapy for liver and lung metastasis of colon cancer].
Tamura J; Nakauchi M; Nakayama Y; Kitaguchi K; Sakikubo M; Ura K; Taira K; Ohe H; Yoshikawa A; Ishigami S; Baba N
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2665-8. PubMed ID: 20009477
[TBL] [Abstract][Full Text] [Related]
24. [A case of advanced ascending colon cancer, curatively resected after complete response in left supraclavicular and paraaortic lymph nodes and liver metastases to FOLFOX4 therapy].
Furumoto K; Kojima H; Takaya H; Okuno M; Fuji H; Mizuno R; Mori T; Ito D; Kogire M
Gan To Kagaku Ryoho; 2010 Feb; 37(2):323-6. PubMed ID: 20154495
[TBL] [Abstract][Full Text] [Related]
25. [A case of drug-induced lung injury associated with chemotherapy (FOLFOX6, FOLFIRI, Bevacizumab) for an advanced colon cancer].
Komaki C; Hanatate F; Kobayashi K
Gan To Kagaku Ryoho; 2011 Jan; 38(1):113-6. PubMed ID: 21368470
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant therapy for colon cancer: the European experience.
Wils J
Tumori; 2001; 87(1 Suppl 1):S85. PubMed ID: 11300039
[No Abstract] [Full Text] [Related]
27. FOLFOXIRI and bevacizumab in metastatic colorectal cancer.
Rahman A
Lancet Oncol; 2014 Dec; 15(13):e590. PubMed ID: 25499288
[No Abstract] [Full Text] [Related]
28. [mFOLFOX6 and FOLFIRI/bevacizumab treatment in a patient on hemodialysis with metastatic colon cancer].
Kuwabara H; Baba H; Wakabayashi M; Nakamura H; Sanada T; Baba H; Nakajima K; Goseki N
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2250-2. PubMed ID: 22202345
[TBL] [Abstract][Full Text] [Related]
29. Liver resection after FOLFOX with bevacizumab.
Mickle M; Mulcahy MF
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
[No Abstract] [Full Text] [Related]
30. Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer?
Nipp RD; Ryan DP
Oncologist; 2015 Mar; 20(3):236-8. PubMed ID: 25660156
[TBL] [Abstract][Full Text] [Related]
31. Surgical removal of metastases after successful treatment containing bevacizumab in metastatic colorectal cancer.
Afonso S; Viani G; Afonso V; Stefano E; Afonso S
Anticancer Drugs; 2011 Jun; 22 Suppl 2():S21-3. PubMed ID: 21768794
[TBL] [Abstract][Full Text] [Related]
32. [An elderly colon cancer patient with hepatic, lunge and peritoneal metastases was treated by hepatic arterial infusion and systemic chemotherapy-a case report].
Ando M; Nagahama T; Fukuda A; Ami K; Kurokawa T; Hataji K; Ganno H; Kawasaki N; Arai K; Okada Y; Tei S
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2288-90. PubMed ID: 21224550
[TBL] [Abstract][Full Text] [Related]
33. [A case of colon cancer with multiple liver metastases responding ot S-1 as third-line treatment following FOLFIRI and FOLFOX].
Miyahira T; Teruya N; Matsuura F; Murayama S; Aka H; Teruya J; Hanashiro N; Nishihara M; Okushima N; Toda Y; Kiyuna M
Gan To Kagaku Ryoho; 2010 Feb; 37(2):331-4. PubMed ID: 20210032
[TBL] [Abstract][Full Text] [Related]
34. [A case of irinotecan or panitumumab-induced interstitial pneumonia successfully treated by steroid pulse therapy].
Yamamoto K; Kato T; Shindo J; Ando M; Abe T; Shiraki A; Nakashima H; Yukita Y
Gan To Kagaku Ryoho; 2012 Feb; 39(2):305-9. PubMed ID: 22333650
[TBL] [Abstract][Full Text] [Related]
35. Panitumumab in metastatic colorectal cancer.
Wisinski KB; Mulcahy MF; Benson AB
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):10-1. PubMed ID: 17491586
[No Abstract] [Full Text] [Related]
36. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
Hatano E; Okuno M; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):634-45. PubMed ID: 25926024
[TBL] [Abstract][Full Text] [Related]
37. [A case of pathologically by complete response in advanced sigmoid colon cancer with multiple metastases of lung and Liver, left hydronephrosis after chemotherapy including bevacizumab/FOLFOX6].
Kubo H; Nishiyama M; Tada K; Miyahara M; Hasegawa H; Yamashita Y
Gan To Kagaku Ryoho; 2012 Jun; 39(6):987-9. PubMed ID: 22705699
[TBL] [Abstract][Full Text] [Related]
38. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
Chang YY; Lin JK; Jiang JK
Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
[No Abstract] [Full Text] [Related]
39. [A successfully resected case of colorectal cancer with multiple liver metastases treated with FOLFIRI after failure of mFOLFOX6].
Fukuda H; Tazawa K; Sawada S; Nagata T; Uotani H; Hirokawa S; Yamagishi F; Tsukada K
Gan To Kagaku Ryoho; 2008 Mar; 35(3):507-9. PubMed ID: 18347406
[TBL] [Abstract][Full Text] [Related]
40. Primary Tumor Resection Offers Higher Survival Advantage in KRAS Mutant Metastatic Colorectal Cancer Patients.
Kodaz H; Erdogan B; Hacibekiroglu I; Turkmen E; Tozkir H; Albayrak D; Uzunoglu S; Cicin I
Hepatogastroenterology; 2015 Jun; 62(140):876-9. PubMed ID: 26902020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
